Volkan Oezdemir accepts 16-month UFC suspension after EPO positive

Volkan Oezdemir will not fight again in 2026, and his return may not come until the middle of next year.

The former UFC light heavyweight title challenger has accepted a 16-month period of ineligibility after erythropoietin, better known as EPO, was detected in out-of-competition urine and blood samples. The suspension began on February 16, 2026, and Oezdemir will be eligible to compete again on June 17, 2027.

There is no contaminated-supplement defence in this case. Oezdemir acknowledged that he injected the substance while recovering from ankle surgery after accepting advice from a healthcare professional who contacted him through Instagram. He also admitted he knew the vial contained EPO and had been told to keep the plan secret.

This was a deliberate shortcut

Oezdemir’s explanation is unusual, but the central fact is simple. He made a conscious decision to use a prohibited substance.

According to his account, the contact initially approached him with talk of business opportunities and life after fighting. The conversation later moved toward recovery, with a plan presented as a fast route back to peak condition. Oezdemir accepted it, administered the injection himself and was later caught by the UFC’s year-round testing program.

His cooperation after the positive result became an important part of the case. He disclosed the circumstances, provided information to the anti-doping authorities and accepted responsibility rather than trying to shift the violation onto somebody else. That cooperation affected the final sanction, but it did not remove the competitive consequences.

• EPO was detected in out-of-competition urine and blood samples.
• The samples were collected on February 16 and March 5, 2026.
• Oezdemir accepted a 16-month UFC anti-doping suspension.
• He can return to UFC competition beginning June 17, 2027.
• Oezdemir admitted that he knowingly injected the banned substance.

The suspension freezes a live contender run

The timing is especially damaging. Oezdemir is 36, remains a recognised name at 205 pounds and was coming off a first-round knockout of Alonzo Menifield in Qatar. He was not rebuilding from the bottom of the roster. He was still close enough to the rankings conversation for one strong booking to matter.

Instead, the division will move forward without him. New contenders will take his potential matchups, veterans will defend their positions and the title picture may look completely different by the time he is cleared. When Oezdemir becomes eligible again, he will be 37 and returning from the longest forced absence of his UFC career.

Responsibility matters more than the sales pitch

The person who offered the recovery plan may become part of a wider investigation, but that does not change the standard applied to a UFC athlete. Fighters are responsible for what enters their bodies, and Oezdemir has not disputed that point.

The detail that makes the case difficult to soften is the secrecy. He was not handed an ordinary treatment and later surprised by a laboratory result. By his own account, the substance was identified, presented as undetectable and accompanied by an instruction not to tell anyone. That moves the story away from negligence and into a clear anti-doping decision.

Oezdemir’s full admission may help him repair some trust, but it cannot return the months he has lost. His last win created momentum. The suspension removes it immediately.

A 2027 comeback now carries a different question

Oezdemir has already rebuilt his UFC career more than once. He recovered from the losses that followed his 2018 title challenge, remained relevant against several generations of light heavyweights and continued to carry the knockout threat that made him a contender in the first place.

If he returns in June 2027, the first question will not be whether he can still hurt elite opponents. It will be whether his body, timing and position in the division survived the layoff. The UFC will also have to decide how quickly a former title challenger should be moved after an anti-doping suspension.

For now, Oezdemir’s place in the division is paused. He took responsibility, accepted the penalty and gave a detailed explanation of how the violation happened. None of that changes the result: a ranked light heavyweight traded a live contender window for a recovery shortcut and will spend the coming months watching the division continue without him.